In 2009, the disinfectant and antiseptic market was worth around $3.4 billion, but by 2010 had grown over 12 percent to reach a value of $3.8 billion, according to reports from Market growth has accelerated in recent years following large scale outbreaks of several infectious diseases, such as MRSA, avian and swine flu, and is expected to rise at a compound annual growth rate (CAGR) of 11.1 percent to reach $7.1 billion by 2016.

The United States constituted approximately 41 percent of the total antiseptics and disinfectants market in 2010 and was around $1.5 billion. The U.S. market is expected to increase to nearly $2.9 billion by 2016 at a CAGR of 11 percent. Europe contributed to about 34 percent of the total market and was $1.3 billion in 2010 and has reached $1.4 billion in 2011. The European market is expected to grow at a CAGR of 11.2 percent and reach $2.4 billion by 2016.

The last decade has seen a rise in the incidence of infectious diseases, and recent outbreaks of swine flu and avian flu have triggered market growth for disinfectants and antiseptic products. These occurrences have heightened public understanding of the serious potential dangers of infection, and the global media coverage which accompanied these incidents has also amplified awareness.

The global antiseptic and disinfectant research report contains 134 pages of insightful market information, with forecast and historical data for the period 2009-2016. The antiseptic market and the disinfectant market are discussed at length, incorporating analysis of key players; existing and future development strategies; products and their modes of action; innovation; patents; trends; M&A/collaborations; growth barriers/drivers; regulations, and other influencing factors.